-
Querfeld, M.D., Ph.D., director of the Cutaneous Lymphoma program, seeks better treatment options for cutaneous T cell lymphoma (CTCL), a rare form of lymphoma that first appears on the skin but can also
-
ensuring access to primary samples from a diverse, nation-wide pool of patients. Our high-throughput science is enabled by state-of-the-art facilities for next-generation sequencing and high-performance
-
medicine, vascular biology, bioengineering, and data science, Dr. Chen leads an active research program focused on epigenetics, RNA and chromatin biology and endothelial stress response. Her team integrates
-
functions of driver genetic lesions in high-risk leukemia subtypes. Perform high-throughput sequencing-based assays to systematically characterize leukemic and normal hematopoietic cells. Interpret multi
-
high-throughput science is enabled by state-of-the-art facilities for next-generation sequencing and high-performance computing through the Translational Genomics Research Institute (TGen) at City of